OnCare Hawaii — Honolulu, Hawaii

OnCare Hawaii is a clinical research site located in Honolulu, Hawaii, United States 96813.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

OnCare Hawaii has participated in 2 clinical trials.

Therapeutic areas: HER2+ Metastatic Breast Cancer (MBC), Acute Myeloid Leukemia.

Sponsors: Puma Biotechnology, Inc., Seagen Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for OnCare Hawaii?

OnCare Hawaii has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has OnCare Hawaii conducted?

OnCare Hawaii has 2 clinical trials on record. Their work covers HER2+ Metastatic Breast Cancer (MBC), Acute Myeloid Leukemia.

Is OnCare Hawaii accredited by Crixeo Health?

OnCare Hawaii has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about OnCare Hawaii?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.